This article in the New York Times describes the innovations and changes that clinical trials have made during the pandemic. At the start of the pandemic, nearly 6,000 of the clinical trials registered on clinicaltrials.gov were stopped. For clinical trials that weren’t stopped, researchers re-designed their clinical trials to include virtual monitoring and remote visits to allow for the study to continue during the pandemic. This has resulted in better access for low-income and other marginalized groups to participate in clinical trials and allowed clinical trial teams to continue research during a difficult time.
At Leapcure, we are firmly committed to clinical research innovations that increase diversity of participation in clinical trials. In addition, virtual components of clinical trials can help advance research during this difficult time and allow for greater flexibility for teams to complete clinical trials. We are excited by these innovations and hope that they inspire long-term changes to clinical trials.